Search results
Showing 151 to 160 of 160 results for surgical site infections
Plus Sutures for preventing surgical site infection (MIB204)
This advice has been updated and replaced by NICE healthtech guidance guidance 586.
hospital stays, revision rates, neurological complications and surgical site infections compared with the posterior and anterolateral...
NICE has developed a medtech innovation briefing (MIB) on fasciotens for abdominal wall closure .
This guideline covers diagnosing and managing abdominal aortic aneurysms. It aims to improve care by helping people who are at risk to get tested, specifying how often to monitor asymptomatic aneurysms, and identifying when aneurysm repair is needed and which procedure will work best.
Evidence-based recommendations on procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay).
NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds .
Tests in secondary care to identify people at high risk of ovarian cancer (HTG453)
Evidence-based recommendations on tests in secondary care to identify people at high risk of ovarian cancer. The tests are the IOTA ADNEX model, Overa (MIA2G), RMI I (at thresholds other than 250), ROMA and IOTA Simple Rules.
Our centralised approach to prioritising guidance topics ensures that we produce guidance that is relevant, timely, accessible, and has demonstrable impact.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Medical technologies guidance on Leukomed Sorbact for preventing surgical site infection (MTG55) Savings are...